Unmet Expectations: miR-34 Plays No Role in p53-Mediated Tumor Suppression In Vivo

article has not abstract

Vyšlo v časopise: Unmet Expectations: miR-34 Plays No Role in p53-Mediated Tumor Suppression In Vivo. PLoS Genet 8(7): e32767. doi:10.1371/journal.pgen.1002859
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002859

Souhrn

article has not abstract

Zdroje

1. SpikeBT, WahlGM (2011) p53, stem cells, and reprogramming: tumor suppression beyond guarding the genome. Genes Cancer 2: 404–419.

2. SoussiT (2007) p53 alterations in human cancer: more questions than answers. Oncogene 26: 2145–2156.

3. HollsteinM, SidranskyD, VogelsteinB, HarrisCC (1991) p53 mutations in human cancers. Science 253: 49–53.

4. HarveyM, McArthurMJ, MontgomeryCAJr, ButelJS, BradleyA, et al. (1993) Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet 5: 225–229.

5. JacksT, RemingtonL, WilliamsBO, SchmittEM, HalachmiS, et al. (1994) Tumor spectrum analysis in p53-mutant mice. Curr Biol : CB 4: 1–7.

6. VousdenKH, PrivesC (2009) Blinded by the light: the growing complexity of p53. Cell 137: 413–431.

7. SahVP, AttardiLD, MulliganGJ, WilliamsBO, BronsonRT, et al. (1995) A subset of p53-deficient embryos exhibit exencephaly. Nat Genet 10: 175–180.

8. HuW, FengZ, TereskyAK, LevineAJ (2007) p53 regulates maternal reproduction through LIF. Nature 450: 721–724.

9. MillsAA, ZhengB, WangXJ, VogelH, RoopDR, et al. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398: 708–713.

10. YangA, WalkerN, BronsonR, KaghadM, OosterwegelM, et al. (2000) p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404: 99–103.

11. ConcepcionCP, HanY-C, MuP, BonettiC, YaoE, et al. (2012) Intact p53-dependent responses in miR-34-deficient mice. PloS Genet 8: e1002792 doi:10.1371/journal.pgen.1002797.

12. BommerGT, GerinI, FengY, KaczorowskiAJ, KuickR, et al. (2007) p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17: 1298–1307.

13. HeL, HeX, LimLP, de StanchinaE, XuanZ, et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447: 1130–1134.

14. Raver-ShapiraN, MarcianoE, MeiriE, SpectorY, RosenfeldN, et al. (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26: 731–743.

15. ChangTC, WentzelEA, KentOA, RamachandranK, MullendoreM, et al. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26: 745–752.

16. TazawaH, TsuchiyaN, IzumiyaM, NakagamaH (2007) Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci U S A 104: 15472–15477.

17. TarasovV, JungP, VerdoodtB, LodyginD, EpanchintsevA, et al. (2007) Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6: 1586–1593.

18. BartelDP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281–297.

19. CalinGA, SevignaniC, DumitruCD, HyslopT, NochE, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101: 2999–3004.

20. HeL, HeX, LoweSW, HannonGJ (2007) microRNAs join the p53 network–another piece in the tumour-suppression puzzle. Nat Rev Cancer 7: 819–822.

21. SpurgersKB, GoldDL, CoombesKR, BohnenstiehlNL, MullinsB, et al. (2006) Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repression. J Biol Chem 281: 25134–25142.

22. LeeKC, CroweAJ, BartonMC (1999) p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding. Mol Cell Biol 19: 1279–1288.

23. LinT, ChaoC, SaitoS, MazurSJ, MurphyME, et al. (2005) p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 7: 165–171.

24. RileyT, SontagE, ChenP, LevineA (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Bio 9: 402–412.

25. HoJ, BenchimolS (2003) Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ 10: 404–408.

26. LinCP, ChoiYJ, HicksGG, HeL (2012) The emerging functions of the p53-miRNA network in stem cell biology. Cell Cycle 11: 2063–72.

27. VersteegR, CaronH, ChengNC, van der DriftP, SlaterR, et al. (1995) 1p36: every subband a suppressor? Eur J Cancer 31A: 538–541.

28. HermekingH (2010) The miR-34 family in cancer and apoptosis. Cell Death Differ 17: 193–199.

29. HermekingH (2007) p53 enters the microRNA world. Cancer Cell 12: 414–418.

30. ChoiYJ, LinCP, HoJJ, HeX, OkadaN, et al. (2011) miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol 13: 1353–1360.

31. KrizhanovskyV, LoweSW (2009) Stem cells: The promises and perils of p53. Nature 460: 1085–1086.

32. JainAK, AlltonK, IacovinoM, MahenE, MilczarekRJ, et al. (2012) p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biol 10: e1001268 doi:10.1371/journal.pbio.1001268.

33. LeucciE, CoccoM, OnnisA, De FalcoG, van CleefP, et al. (2008) MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J Pathol 216: 440–450.

34. JiQ, HaoX, ZhangM, TangW, YangM, et al. (2009) MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PloS ONE 4: e6816 doi:10.1371/journal.pone.0006816.

35. CorneyDC, Flesken-NikitinA, GodwinAK, WangW, NikitinAY (2007) MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 67: 8433–8438.

36. WelchC, ChenY, StallingsRL (2007) MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26: 5017–5022.